< Back to previous page
Publication
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR) : results from a randomised, placebo-controlled, phase 2 trial
Journal Contribution - Journal Article
Journal: LANCET
ISSN: 1474-547X
Issue: 10162
Volume: 392
Pages: 2367 - 2377
Publication year:2018
BOF-keylabel:yes
IOF-keylabel:yes
BOF-publication weight:10
CSS-citation score:3
Authors:International
Authors from:Private
Accessibility:Closed